CAR-T therapy aids systemic lupus erythematosus remission

Promising early study results for a personalised CAR T-cell therapy facilitated remission for lupus patients given the anti-CD19 therapy.

Related Keywords

Germany ,German ,Daniel Baker ,University Of Pennsylvania ,Perelman School Of Medicine ,Cellular Immunotherapies At Penn Abramson Cancer Center ,Laboratory Medicine At Penn ,Richardw Vague Professor ,Laboratory Medicine ,Penn Medicine ,Abramson Cancer ,Molecular Biology ,Perelman School ,